The reviewers commented on the thoroughness and high quality of the experimental work, and felt that it provides new insights into how Scribble and Dlg are associated with expression and localization of junctional proteins. However, there were a few key points that need to be addressed before the manuscript could be considered acceptable for publication by JCB. Therefore, while we cannot accept the manuscript in its present form, we invite you to submit a suitably revised version, together with a point-by-point response to each of the reviewer comments. Most likely I will be able to make a final decision without sending out the revised manuscript for re-evaluation.
One key point, raised by reviewer #2, concerns the pulldown of endogenous Scrib and SGEF by an anti-Dlg1 antibody (Fig. 3B ). As the reviewer notes, this is a very important experiment because a physical interaction between Scrib and Dlg has been somewhat controversial, and they suggest performing the same IP but with cells depleted of SGEF, as a negative control. They also suggest IF staining for endogenous SGEF, but I am not sure that this is feasible with existing antibodies, so I do not consider this to be essential. Reviewer #3 would also like to see the effect of SGEF depletion on Scrib/Dlg localization. Other comments of the reviewers can mostly be addressed by modifications to the text.
While you are revising your manuscript, please also attend to the following editorial points to help expedite the publication of your manuscript. Please direct any editorial questions to the journal office.
GENERAL GUIDELINES:
Text limits: Character count for an Article is < 40,000, not including spaces. Count includes title page, abstract, introduction, results, discussion, acknowledgments, and figure legends. Count does not include materials and methods, references, tables, or supplemental legends. pronounced effects than SGEF on cell polarity. These results suggest that SGEF might affect pathways in addition to the Scribble pathway to maintain cell-cell junctions. Interestingly, depleting SGEF in MDCK cells results in increased organization of contractile actin networks at apical junctions and on the basal surface while over expressing SGEF in Xenopus embryos induces constriction implying an increase in apical contractility. The results show that SGEF has a pronounced effect on actomyosin organization, but the mechanism is likely to be complicated. The authors show, for example, that SGEF's effect on myosin II organization is independent of SGEF's catalytic domain. These results suggest a scaffolding function for SGEF in building a Scribble-SGEF-Dlg1 complex is key for epithelial contractility. The results represent a significant advance in the molecular mechanisms organizing epithelial cells while identifying SGEF as relatively new player in these processes. In addition, the study reveals a new, important role for Scribble and Dlg1 in controlling SGEF localization/activity.
The writing is clear. The experiments are well organized and logical. The methods section has sufficient detail for others to build upon the work.
All of the data is strong. Evidence supporting an SGEF-Scribble and SGEF-Dlg1 binding interactions, while semi-quantitative, are compelling as is the demonstration of a ternary complex. Mapping of the binding sites is detailed and convincing. We are even given a crystal structure of the Scribble PDZ1 domain bound to associated SGEF peptide. Therefore, the biochemistry is solid.
The cell biology and physiology is also good. The imaging is of high quality and quantitation is provided for all imaging experiments. Effects of depleting SGEF on E-cadherin, tight junction organization, myosin organization, tight junction function, and lumen formation are all convincing as is the effect of over-expression on apical constriction.
In general, not much to criticize here while we learn a lot about SGEF in epithelial cells..
Reviewer #2 (Comments to the Authors (Required)):
Awadia et al describe a novel interaction between the polarity protein, Scribble, and the GEF for RhoG, SGEF. The finding is novel, and provides an alternative to the linking function of GuKholder in Drosophila, resolving a longstanding gap in the field. For the most part, the experiments are well performed, well analysed, and well controlled, and the conclusions appropriate to the data. They first show using a series of comprehensive co-immunoprecipitations with overexpressed, tagged, mutated or wild-type Scribble and SGEF, that the binding site is an unorthodox interaction between the PDZ1 domain of Scribble and an internal peptide sequence in SGEF. They then perfom X-ray crystallography to sole the structure of the Scribble PDZ1 binding a 10 aa peptide comprising this sequence, and show that the peptide inserts into the PDZ-binding pocket with greater coverage than the more common C-terminal binding.
Having previously shown that SGEF binds to a functional partner of Scribble, Dlg, they revisit the binding site interactions described in this previous paper (Krishna Subbaiah et al., 2012) , but find a different region responsible for the association between Dlg and SGEF. Here, they find that the GuK domain of Dlg1 is required, rather than the PDZ and SH3 domains reported previously. An explanation for this discrepancy is not provided.
The authors demonstrate an SGEF-dependent co-immunoprecitptation of overexpressed Dlg and Scribble, and also show pulldown of endogenous Scribble and SGEF using an antibody to Dlg1 ( Fig  3B) . Fig 3B is a critical experiment, particularly because an interaction between mammalian Scribble and Dlg has not previously been convincingly demonstrated, and was not adequately described. What was the control -an isotype control for the Dlg antibody? Were only 4 washes performed on these immunoprecipitations. Particularly given that significantly less Scribble appeared in the IP compared with the input (what was the ratio of lysate in the input compared to the IP), other controls (such as knockdown of SGEF in the cell line) are needed to show that this was not just 'stickiness' of the Scribble protein. And given the putative role of SGEF as an adaptor, overexpression of SGEF is likely to also disrupt the interaction between Dlg1 and Scribble, providing another opportunity to verify this finding.
The authors show co-localisation of mNeon-tagged SGEF with Dlg and Scribble at lateral junctions in MCF10A and at AJC in Xenopus embryos, but do not assess localisation of endogenous SGEF. Structure function analyses indicated that Scribble binding was required for this localisation.
Knockdown of SGEF led to clear mis-localisation of catenins, and Dlg, and loss of Ecad. Scribble was also somewhat mis-localised (see minor points below). The cells lost their cuboidal shape, tight junction morphology and barrier function, and actomyosin contractility. These phenotypes were all restored with mNeon-SGEF WT, which validated both the phenotypes and the tagged construct. Overexpression of SGEF in Xenopus embryos led to increased apical constriction, associated with reorganised actin, myosin II ad vinculin. Structure-function studies showed a differential requirement for scaffolding and catalytic activity in the MDCK phenotypes, and 3D MDCK cyts reveals a role for SGEF in lumen formation, and again, the scaffolding and catalytic domains played different roles.
Together, these experiments form a comprehensive and well-executed set of observations that show a clear role for SGEF in mediating cell-cell junctions, and begin to define the molecular mechanism by which scaffolding of the Scribble complex is associated with expression and localisation of junctional proteins.
Major concerns
The copimmunoprecipitation of endogenous Scribble and Dlg in the presence of SGEF should be validated with better controls, such as knockdpwn, and/or overexpression of SGEF.
Minor points. The reason for the discrepancy between data from the Krishna Subbaiah et al., 2012 paper and this one should be explored. That Scribble is required for SGEF recruitment to junctions does not preclude a role for SGEF in Scribble localisation as suggested (las paragraph, p7). The two proteins could have mutual dependence for localisation. The authors seem to observe a mislocalisation of Scribble but downplay it for no objective reason, where in fact the quantitation in Fig 5G suggests a clearer phenotype for Scribble than for Dlg1. It seems more appropriate not to downplay the phenotype for Scribble .
Reviewer #3 (Comments to the Authors (Required)):
Garcia-Mata1218
Allowing epithelial cell shape change during normal development while maintaining epithelial integrity and barrier function requires regulated interactions between cell-cell and cell matrix junctions and the actomyosin cytoskeleton. The MDCK cell model serves as an outstanding place to explore this. Here Awadia et al provide interesting and novel insights into this process. They begin by identifying a highly novel role for a RhoG specific GEF, SGEF, in mediating interactions between two key polarity proteins, Scribble and Dlg. They then go on to characterize the location and function of SGEF in MDCK cells and the Xenopus embryo, revealing roles in modulating Ecadherin localization, and actomyosin localization and contractility. These results are quite intriguing, and will be of broad interest to cell and developmental biologists. However, these are some issues that need to be addressed and which would strengthen the manuscript-some simply require clarification or text modifications and all should be well within the abilities of the authors in a reasonable amount of time.
1. One issue is that the manuscript is essentially two papers joined in the middle. The first four figures lay our very clearly and carefully that SGEF is required for linking Scribble and Dlg. However, in the rest of the paper little or no mention is made of this-to the extent that the authors do not even tell us if SGEF knockdown alters Scribble or Dlg localization. I am OK with the deviation in topic in mid-steam, as they needed to follow the phenotype where it led,, but this simple question should certainly be easy to answer. 2. The reduction in total Ecadherin levels and localization to AJs without concomitant changes in beta-catenin was convincing and described fairly clearly in the text. However, I thought Panels in Figure 5C and G included some data that overstated the facts. In the lower mag images of multiple cells its clear that the effect on Ecad and p120 localization are somewhat variable cell to cell. The high mag boxes and the line scans in Fig 5G highlight the regions of most extreme loss. This should be corrected. 3. Figure 8A was quite striking, but the variability in apical area left me wondering if their expression system is leading to mosaic expression with different amounts of SGEF OE in different cells. Is it possible to address this?
Minor issues with Figures
1. I must admit I was left a bit confused about the localization of SGEF along the apical-basal axis with respect to that of Scribble and Dlg. The lovely images and quantification in Figure 4C -D clearly place SGEF with respect to TJ and AJ markers, but how do Scribble and Dlg fit into this-doe they also colocalize with TJs and AJs. The Z slices in Fig. 4A -B are difficult to interpret, especially without single channel images. 2. Figure 9H . Too many different lines that are hard to distinguish are included.
Other comments
The Introduction should be expanded to tell us what we know about the role of Scribble in MDCK cells, from earlier work by the Macara lab, and to tell us what we know about SGEF from earlier work.
How does the reduction in TEER compare to that seen with ZO family protein are knocked down or knocked out? 
…the results represent a significant advance in the molecular mechanisms organizing epithelial cells while identifying SGEF as relatively new player in these processes. In addition, the study reveals a new, important role for Scribble and Dlg1 in controlling SGEF localization/activity.
All of the data is strong. Evidence supporting an SGEF-Scribble and SGEF-Dlg1 binding interactions, while semiquantitative, are compelling as is the demonstration of a ternary complex. Mapping of the binding sites is detailed and convincing. We are even given a crystal structure of the Scribble PDZ1 domain bound to associated SGEF peptide. Therefore, the biochemistry is solid.
The cell biology and physiology are also good. The imaging is of high quality and quantitation is provided for all imaging experiments. Effects of depleting SGEF on E-cadherin, tight junction organization, myosin organization, tight junction function, and lumen formation are all convincing as is the effect of over-expression on apical constriction. In general, not much to criticize here while we learn a lot about SGEF in epithelial cells.
-We thank the reviewer's enthusiastic assessment about our work.
Awadia et al describe a novel interaction between the polarity protein, Scribble, and the GEF for RhoG, SGEF. The finding is novel and provides an alternative to the linking function of GuKholder in Drosophila, resolving a longstanding gap in the field. For the most part, the experiments are well performed, well analysed, and well controlled, and the conclusions appropriate to the data.
-We thank the reviewer for the positive feedback about our work.
They first show using a series of comprehensive co-immunoprecipitations with overexpressed, tagged, mutated or wild-type Scribble and SGEF, that the binding site is an unorthodox interaction between the PDZ1 domain of Scribble and an internal peptide sequence in SGEF. They then perfom X-ray crystallography to solve the structure of the Scribble PDZ1 binding a 10 aa peptide comprising this sequence, and show that the peptide inserts into the PDZ-binding pocket with greater coverage than the more common C-terminal binding.
-We have now added a section in the discussion (page 15), explaining the potential causes of this discrepancy (see fragment added below).
"Our results show that that the interaction is mediated by the GUK domain of Dlg1 and a stretch of 50 aa in SGEF's N-terminus. However, a previous report had described the interaction between SGEF and Dlg1 and mapped the interaction to SGEF's PBM and Dlg1's PDZ domains 1-2 (Krishna Subbaiah et al., 2012) . Interestingly, the initial report also showed that, SGEF and Dlg1 were able to interact when the PBM in SGEF and PDZ domains in Dlg1 were deleted. Moreover, the GUK domain of Dlg1 was shown to interact with a mutant of SGEF in which the SH3 and PBM were deleted. It is possible that the PBM-PDZ interaction observed by Krishna Subbaiah and colleagues resulted from the way these assays were performed, i.e. using high concentration of GST-tagged proteins expressed in bacteria. The specificity of a PDZ-PBM interaction in vitro only demonstrates its potential binding capability, but it does not necessarily mean that interaction should exist in vivo. Here, the C-term of SGEF has the potential to bind Dlg1 in vitro but our data indicates it does not bind in vivo."
The authors demonstrate an SGEF-dependent co-immunoprecitptation of overexpressed Dlg and Scribble, and also show pulldown of endogenous Scribble and SGEF using an antibody to Dlg1 (Fig 3B) . Fig 3B is a critical experiment, particularly because an interaction between mammalian Scribble and Dlg has not previously been convincingly demonstrated, and was not adequately described. What was the control -an isotype control for the Dlg antibody? Were only 4 washes performed on these immunoprecipitations. Particularly given that significantly less Scribble appeared in the IP compared with the input (what was the ratio of lysate in the input compared to the IP), other controls (such as knockdown of SGEF in the cell line) are needed to show that this was not just 'stickiness' of the Scribble protein. And given the putative role of SGEF as an adaptor, overexpression of SGEF is likely to also disrupt the interaction between Dlg1 and Scribble, providing another opportunity to verify this finding.
-We have now updated the legend in Fig. 3 as well as the Methods section to provide more details on the immunoprecipitation described in Fig. 3B . One of the reasons that less Scribble appears in the IP compared with the input is that Scribble is the secondary interaction. We IP Dlg1, which binds to SGEF, which simultaneously interacts with Scribble. In our hands, the recovery efficiency of the secondary interaction (Scrib) is not as high as the primary (SGEF). Therefore, we recover more SGEF than Scribble compared to their inputs. In the revised version, we have now performed additional experiments which demonstrate -with endogenous proteins -that when SGEF is knocked down, the amount of Scribble that co-immunoprecipitates with Dlg1 is significantly decreased. The new results are now shown in Fig. 3C .
-We have now optimized the conditions for using the SGEF antibody for immunofluorescence in MDCK cells. Our new results show that, as expected, endogenous SGEF localizes to junctions. We have added a new panel describing our results (Fig. S2A) .
-We thank the reviewer again for considering our work comprehensive and well-executed.
Major concerns
The co-immunoprecipitation of endogenous Scribble and Dlg in the presence of SGEF should be validated with better controls, such as knockdown, and/or overexpression of SGEF.
-See comments above. The new results are now presented in Fig. 3C Minor points. The reason for the discrepancy between data from the Krishna Subbaiah et al., 2012 paper and this one should be explored.
-See comments above. The new text has been added to the Discussion section (p15 first paragraph).
That Scribble is required for SGEF recruitment to junctions does not preclude a role for SGEF in Scribble localisation as suggested (las paragraph, p7). The two proteins could have mutual dependence for localisation. The authors seem to observe a mislocalisation of Scribble but downplay it for no objective reason, where in fact the quantitation in Fig 5G suggests a clearer phenotype for Scribble than for Dlg1. It seems more appropriate not to downplay the phenotype for Scribble .
-The reviewer raises an important point. Based on the phenotype observed in cells (Fig. 5E-F) , we still think the phenotype is more severe for Dlg1. The reviewer is right to point out that the quantification does indicate that Scribble is also affected. However, the decrease in intensity at the peak (signal at the junction) is more pronounced for Dlg1 than for Scribble. In the revised version, we have modified the text in page 8 (2 nd paragraph) to better reflect the phenotypes observed.
Comments to the Authors (Required)): Garcia-Mata1218
Allowing epithelial cell shape change during normal development while maintaining epithelial integrity and barrier function requires regulated interactions between cell-cell and cell matrix junctions and the actomyosin cytoskeleton. The MDCK cell model serves as an outstanding place to explore this. Here Awadia et al provide interesting and novel insights into this process. They begin by identifying a highly novel role for a RhoG specific GEF, SGEF, in mediating interactions between two key polarity proteins, Scribble and Dlg. They then go on to characterize the location and function of SGEF in MDCK cells and the Xenopus embryo, revealing roles in modulating E-cadherin localization, and actomyosin localization and contractility. These results are quite intriguing, and will be of broad interest to cell and developmental biologists. However, these are some issues that need to be addressed and which would strengthen the manuscript-some simply require clarification or text modifications and all should be well within the abilities of the authors in a reasonable amount of time.
-We thank the reviewer for considering our findings to be of broad interest for cell and developmental biologists.
1. One issue is that the manuscript is essentially two papers joined in the middle. The first four figures lay our very clearly and carefully that SGEF is required for linking Scribble and Dlg. However, in the rest of the paper little or no mention is made of this-to the extent that the authors do not even tell us if SGEF knockdown alters Scribble or Dlg localization. I am OK with the deviation in topic in mid-steam, as they needed to follow the phenotype where it led, but this simple question should certainly be easy to answer. -We apologize if this was not properly emphasized in the text, but in the original version, we did include experiments that analyzed the localization of Scribble and Dlg1 in SGEF KD cells. The results were shown in Fig.  5E-F and quantified in 5G . The data show that junctional Dlg1 localization is affected more severely than Scribble, which is only somewhat more diffuse in SGEF KD cells. We have also modified the accompanying text to make the point more clearly, addressing the comments of reviewers 2 and 3.
2. The reduction in total E-cadherin levels and localization to AJs without concomitant changes in beta-catenin was convincing and described fairly clearly in the text. However, I thought Panels in Figure 5C and G included some data that overstated the facts. In the lower mag images of multiple cells it's clear that the effect on Ecad and p120 localization are somewhat variable cell to cell. The high mag boxes and the line scans in Fig 5G  highlight the regions of most extreme loss. This should be corrected.
-We agree with the reviewer's comments. We have corrected Fig. 5 to show a high magnification picture that is more representative of the decrease in E-cadherin expression. The images shown are from a mixed population of stable SGEF KD cells, so it is expected that the expression levels of SGEF may vary from cell to cell. We now provide data from stable SGEF KD cells isolated from single cell clones that show a more uniform reduction of Ecadherin overall (Fig. S2 F) and discuss the difference between the two types of SGEF KD cells used in the text (page 7).
3. Figure 8A was quite striking, but the variability in apical area left me wondering if their expression system is leading to mosaic expression with different amounts of SGEF OE in different cells. Is it possible to address this? -We thank the reviewer for appreciating the striking image in Fig. 8A . When mRNAs are injected into Xenopus embryos (at the 4-cell stage here), there can be some mosaicism in how much protein each cell expresses when imaged at a later time (at the gastrula stage here). However, as you can see in the corresponding GFP channel for this image, each of the cells in the field of view appears to express 3xGFP-SGEF at a similar level. Therefore, the variability in apical area is likely due to some cells initiating apical constriction, and their neighbor cells elongating their junctions to compensate.
Minor issues with Figure  1 . I must admit I was left a bit confused about the localization of SGEF along the apical-basal axis with respect to that of Scribble and Dlg. The lovely images and quantification in Figure 4C -D clearly place SGEF with respect to TJ and AJ markers, but how do Scribble and Dlg fit into this-do they also colocalize with TJs and AJs. The Z slices in Fig. 4A-B are difficult to interpret, especially without single channel images.
-We agree with the reviewer's comments. We have observed a more restricted localization for SGEF at the very apical region in Xenopus embryos when compared to MDCKs where SGEF localizes more broadly along the lateral membrane. In the revised version, we have corrected Figure 4A -B to show single channel grayscale images.
2. Figure 9H . Too many different lines that are hard to distinguish are included.
-The reviewer raises a fair point. It is a difficult problem since the overlapping lines have very similar values. After trying several ways to graph these results, we have substituted the original graph with a modified version with a break in the y-axis that better shows the differences between the lines.
Other comments
-We have expanded the Introduction to cover some of the early work on Scribble and Dlg1 in mammalian cells.
How does the reduction in TEER compare to that seen with ZO family protein are knocked down or knocked out? -KD/KO of ZO-1 or ZO-1/2 does not seem to affect TEER in general although it does affect permeability of larger solutes. This is indicated in the Discussion (p16, second paragraph Thank you for submitting your revised manuscript entitled "SGEF forms a complex with Scribble and Dlg1 and regulates epithelial junctions and contractility". We would be happy to publish your paper in JCB pending final revisions necessary to meet our formatting guidelines (see details below).
To avoid unnecessary delays in the acceptance and publication of your paper, please read the following information carefully.
A. MANUSCRIPT ORGANIZATION AND FORMATTING:
Full guidelines are available on our Instructions for Authors page, http://jcb.rupress.org/submission-guidelines#revised. **Submission of a paper that does not conform to JCB guidelines will delay the acceptance of your manuscript.** 1) Text limits: Character count for Articles and Tools is < 40,000, not including spaces. Count includes title page, abstract, introduction, results, discussion, acknowledgments, and figure legends. Count does not include materials and methods, references, tables, or supplemental legends. We realize that you are somewhat over this limit at the moment but we should be able to give you the extra space this time. However, please try not to add to the current length of the text.
2) Figures limits:
Articles and Tools may have up to 10 main text figures. You currently meet this limit but please bear it in mind when revising.
3) Figure formatting : Scale bars must be present on all microscopy images, including inset magnifications. Molecular weight or nucleic acid size markers must be included on all gel electrophoresis, including cropped gels. Currently, none of you gels include weight markers so they will need to be added to each figure. 4) Statistical analysis: Error bars on graphic representations of numerical data must be clearly described in the figure legend. The number of independent data points (n) represented in a graph must be indicated in the legend. Statistical methods should be explained in full in the materials and methods. For figures presenting pooled data the statistical measure should be defined in the figure legends. Please also be sure to indicate the statistical tests used in each of your experiments (both in the figure legend itself and in a separate methods section) as well as the parameters of the test (for example, if you ran a t-test, please indicate if it was one-or two-sided, etc.). Also, since you used parametric tests in your study (e.g. t-tests, ANOVA, etc.), you should have first determined whether the data was normally distributed before selecting that test. In the stats section of the methods, please indicate how you tested for normality. If you did not test for normality, you must state something to the effect that "Data distribution was assumed to be normal but this was not formally tested." 5) Materials and methods: Should be comprehensive and not simply reference a previous publication for details on how an experiment was performed. Please provide full descriptions (at least in brief) in the text for readers who may not have access to referenced manuscripts. 6) Please be sure to provide the sequences for all of your primers/oligos and RNAi constructs in the materials and methods. You must also indicate in the methods the source, species, and catalog numbers (where appropriate) for all of your antibodies. 7) Microscope image acquisition: The following information must be provided about the acquisition and processing of images: a. Make and model of microscope b. Type, magnification, and numerical aperture of the objective lenses c. Temperature d. imaging medium e. Fluorochromes f. Camera make and model g. Acquisition software h. Any software used for image processing subsequent to data acquisition. Please include details and types of operations involved (e.g., type of deconvolution, 3D reconstitutions, surface or volume rendering, gamma adjustments, etc.). 8) References: There is no limit to the number of references cited in a manuscript. References should be cited parenthetically in the text by author and year of publication. Abbreviate the names of journals according to PubMed. 9) Supplemental materials: There are strict limits on the allowable amount of supplemental data. Articles/Tools may have up to 5 supplemental figures. You currently meet this limit but please bear it in mind when revising. Please also note that tables, like figures, should be provided as individual, editable files. A summary of all supplemental material should appear at the end of the Materials and methods section. 10) Conflict of interest statement: JCB requires inclusion of a statement in the acknowledgements regarding competing financial interests. If no competing financial interests exist, please include the following statement: "The authors declare no competing financial interests." If competing interests are declared, please follow your statement of these competing interests with the following statement: "The authors declare no further competing financial interests." 11) ORCID IDs: ORCID IDs are unique identifiers allowing researchers to create a record of their various scholarly contributions in a single place. At resubmission of your final files, please consider providing an ORCID ID for as many contributing authors as possible.
B. FINAL FILES:
Please upload the following materials to our online submission system. These items are required prior to acceptance. If you have any questions, contact JCB's Managing Editor, Lindsey Hollander (lhollander@rockefeller.edu).
--An editable version of the final text (.DOC or .DOCX) is needed for copyediting (no PDFs).
--High-resolution figure and video files: See our detailed guidelines for preparing your productionready images, http://jcb.rupress.org/ fig-vid -guidelines.
--Cover images: If you have any striking images related to this story, we would be happy to consider them for inclusion on the journal cover. Submitted images may also be chosen for highlighting on the journal table of contents or JCB homepage carousel. Images should be uploaded as TIFF or EPS files and must be at least 300 dpi resolution. **It is JCB policy that if requested, original data images must be made available to the editors. Failure to provide original images upon request will result in unavoidable delays in publication. Please ensure that you have access to all original data images prior to final submission.** **The license to publish form must be signed before your manuscript can be sent to production. A link to the electronic license to publish form will be sent to the corresponding author only. Please take a moment to check your funder requirements before choosing the appropriate license.** Thank you for your attention to these final processing requirements. Please revise and format the manuscript and upload materials within 7 days.
Please contact the journal office with any questions, cellbio@rockefeller.edu or call (212) 327-8588.
Thank you for this interesting contribution, we look forward to publishing your paper in Journal of Cell Biology. 
